Back to Top Skip to main content Skip to sub-navigation

Army CID forensics team on the frontline of the COVID-19 pandemic

Three lab technicians in full PPE looking at computer screen Dr. Roman Aranda, Supervisory Chemist, and Dr. Bo Liu, Chemist, process samples on the Panther Fusion at the Dwight D. Eisenhower Army Medical Center at Fort Gordon, Georgia. (Photo by: Jeffrey Castro.)

Recommended Content:

Coronavirus | Heroes Behind the Mask

In the middle of March as the COVID-19 pandemic spread across the United States, the Army made mission adjustments to focus on protecting the force, posturing for global operational readiness, and supporting the national effort to fight the new novel coronavirus.

"U.S. Army researchers were critical during the SARS epidemic, the Zika virus and the Ebola outbreak as they helped develop antivirals and vaccines," said Ryan McCarthy, Secretary of the Army, in an April 1, U.S. Army press release. "They've done it before and they will do it again."

During this timeframe, a team from the U.S. Army Criminal Investigation Command’s Defense Forensic Science Center’s (DFSC) Forensic Exploitation Directorate (FXD) collectively identified the required skills, training and equipment needed to conduct COVID-19 testing.

“At the early onset of the COVID-19 pandemic, we (DFSC FXD) understood the severity and global impact the virus would have,” said Crystal Allen, chief, Forensic Exploitation Branch 2 within the FXD. “We knew very quickly that given the organic skillset of the FXD examiners that we could assist the medical community with testing. Our support ultimately provided the Department of Defense with additional resources across the globe to support the ever-increasing demand for COVID-19 testing.”

Located on the Gillem Enclave in Forest Park, Georgia, the DFSC's mission is to provide full-service forensic and biometric support to Army and Department of Defense entities worldwide. This includes the subordinate units of U.S. Army Criminal Investigation Laboratory, FXD, Biometrics Operations Directorate, and the Office of Quality Initiatives and Training. The FXD houses the capability to deploy a scalable and modular forensic exploitation team to provide the joint force commander or combatant command with a deployable forensic capability.

Five months later, a team from FXD continues to support COVID-19 testing in support of military forces.

According to Allen, the initial planning team of seven individuals formed in mid-March and was tasked early on with concept development.

The team used their vast scientific and operational expertise to learn proper medical testing procedures and requirements in order to establish a way ahead to support the DoD.

Despite not having used the Panther Fusion, BioFire, or Gene Expert platforms before, the FXD examiners used their knowledge and skillsets in complex scientific instrumentation and sample handling to adapt, said Allen. These platforms utilize polymerase chain reaction (PCR) technology, much like the FXD examiners utilize to conduct forensic DNA testing.

“FXD's support to COVID processing improved the U.S. military's readiness and provided enhanced value to the U.S. government,” said Allen. “The FXD's support helped to identify service members testing positive within basic training formations, deploying units, mobilized National Guard units, Navy ships, and Marine Expeditionary Forces so commanders could isolate those infected personnel in order to preserve the readiness of the remainder of the Joint Forces.”

Since March, dozens of FXD Forensic DNA examiners, latent print examiners, and explosive/drug chemists have deployed to work in military medical treatment facilities at Fort Gordon, Georgia; and Camp Humphreys, Korea in support of U.S. Army Medical Command (USAMEDCOM). They have also deployed to Camp Ripley, Minnesota, in support of a mobile medical lab set up to handle COVID-19 specimen testing in remote locations.

Allen said, CID’s FXD team transformed their current forensic instrumentation and software into a viral testing capability and also modified five mobile forensic laboratories to meet the needs of medical testing facilities for rapid deployment into austere locations.

The mobile forensic labs have aided in expedited testing and allowed military personnel to be tested without having to mail tests to another medical location.

The transformation from a forensic science capability into a medical testing capability required exhaustive research, planning, contract modifications and countless hours of coordination with the DFSC staff, CID staff, USAMEDCOM, numerous scientific vendors, the Center for Disease Control and the U.S. Food and Drug Administration, Allen stated.

The FXD has significantly impacted the fight during the COVID-19 pandemic with noticeable results by providing more than 8,100 hours of support and processed more than 47,530 DoD COVID-19 samples as of Aug. 11. In addition to the significant number of samples the FXD team was able to process, they were also able to provide their USAMEDCOM partners with novel testing concepts and efficient processing mechanisms based on their experience working in high OPTEMPO forensic laboratories.

The team has processed samples submitted from Basic Training formations at Fort Benning, Georgia; deploying units from Fort Campbell, Kentucky; mobilized National Guard units preparing for rotations at the Combat Training Centers; forward deployed military units along the Demilitarized Zone (DMZ) in South Korea; and Marine Expeditionary Forces in Okinawa, Japan, to name a few.

“Our FXD Teams continue a high level of support to USAMEDCOM with COVID-19 Testing,” said COL Jeremy Willingham, executive director, DFSC, after processing 8,000 swabs in one week alone. “In one single day the FXD team accessioned, packaged, and shipped 2,820 specimens from the USS America, USS Ronald Reagan, USS New Orleans, U.S. Naval Hospital in Okinawa, and Camp Humphreys.”

The primary mission for FXD is global forensic exploitation support. However, the forward leaning innovative thinking led to FXD truly supporting a full range of military operations, to include the global fight against this novel threat, said Allen.

You also may be interested in...

It’s Not Over Yet: Some COVID Safety Precautions Remain Necessary

Article
7/22/2021
a crowd of people

Returning to society when fully vaccinated is great but keep that mask handy

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus

How COVID-19 fast-tracked innovation in the Military Health System

Article
7/20/2021
Military personnel receiving the COVID-19 test

As the COVID-19 pandemic disrupted every aspect of healthcare delivery, the Military Health System responded with new and innovative ways to fight the disease and deliver safe, quality care to patients.

Recommended Content:

Health Innovation Month | Innovation | COVID-19 Vaccine Toolkit | Coronavirus

COVID vaccinations rise -- but so do concerns of the Delta variant

Article
7/1/2021
Military personnel wearing a face mask preparing a COVID-19 vaccine

MHS expected to reach 70% COVID-10 vaccination rate in July.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

New COVID-19 Delta Variant: What You Need to Know to Stay Safe

Article
6/28/2021
Military personnel receiving the COVID-19 vaccine

COVID-19 Delta variant spreading rapidly; it’s time to get vaccinated

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Delta Variant

Army’s 773rd administers mobile COVID-19 testing during DEF21

Article
6/4/2021
Three military personnel, wearing masks and lab coats, pose for a picture in an Albanian lab.

Approximately 800 Army Reserve soldiers from the U.S. and Europe participated in DEFENDER-Europe 21.

Recommended Content:

Health Readiness | Coronavirus | COVID-19 Vaccine Toolkit | Readiness Capabilities

Mental Health Panel Discusses Impact of COVID-19

Article
6/3/2021
Military personnel wearing face mask speaking on a panel

Walter Reed Bethesda hosts mental health panel to discuss the impacts of COVID-19.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | Psychological Fitness

Based on data, MHS experts encourage vaccines for adolescents

Article
6/1/2021
Sister and brother smiling at each other

With the Pfizer vaccine approved for youth ages 12 to 15, MHS adolescents are lining up to get the COVID-19 vaccine.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts | Children's Health | Vaccine Eligibility

“Shots in arms” – OPT planned & coordinated to meet COVID-19 mission

Article
5/28/2021
Military personnel sitting around a table talking

The Department of Defense’s COVID-19 Operational Planning Team has been the quiet force behind the DOD’s vaccination effort since November.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus

Adolescents ages 12 and older eligible for COVID-19 vaccinations

Article
5/27/2021
Son of military personnel receiving his COVID-19 vaccine

Pfizer vaccine now authorized for children 12 and older.

Recommended Content:

Children's Health | COVID-19 Vaccine Toolkit | Coronavirus

COVID-19 Town Hall with RADM Anne M. Swap

Article
5/24/2021
MHS and Military OneSource NCR COVID-19 Town Hall with Rear Admiral Anne M. Swap, Director, National Capital Medical Directorate, Wednesday, May 26 at 11:50 a.m. ET

The purpose of this event is to inform National Capital Region (NCR) beneficiaries of DHA’s efforts with battling coronavirus (COVID-19) and encourage them to not delay care.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts | MHS and Military OneSource To Your Health

Adirim, Place laud DHA response to COVID-19 in briefing

Article
5/21/2021
Defense Health Agency Director Lt. Gen. (Dr.) Ronald J. Place speaking at a press conference

Dr. Terry Adirim, acting assistant secretary of defense for health affairs, and Army Lt. Gen. (Dr.) Ronald J. Place, director of the Defense Health Agency, provided a COVID-19 update during a Pentagon press briefing.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus

Sailors continue to receive COVID-19 vaccine

Article
5/20/2021
Military personnel wearing a face mask receiving the COVID-19 vaccine

Sailors continue to voluntarily receive one of the three available COVID-19 vaccines.

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts

MHS quickly adapted to improve patient experience during pandemic

Article
5/19/2021
Military health personnel waiting for the next phone call on the COVID-19 advice line

MHS adapted technology to boost patient experience during pandemic

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus

DHA Director visits MCAGCC to hear from the ‘Boots on the Ground’

Article
5/19/2021
Military personnel wearing face masks walking

DHA Director visits Marine Corps Air Ground Combat Center Twentynine Palms.

Recommended Content:

MHS GENESIS | Military Health System Transformation | Coronavirus | COVID-19 Vaccine Toolkit

Palliative care provides comfort to COVID-19 patients, families

Article
5/17/2021
Military health personnel taking care of a patient

Medical Center team develops palliative care toolkit for COVID-19 patients

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 25

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.